BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11533227)

  • 1. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.
    Hrdlicková R; Nehyba J; Bose HR
    Mol Cell Biol; 2001 Oct; 21(19):6369-86. PubMed ID: 11533227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.
    Nehyba J; Hrdlicková R; Burnside J; Bose HR
    Mol Cell Biol; 2002 Jun; 22(11):3942-57. PubMed ID: 11997525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP-1 factors play an important role in transformation induced by the v-rel oncogene.
    Kralova J; Liss AS; Bargmann W; Bose HR
    Mol Cell Biol; 1998 May; 18(5):2997-3009. PubMed ID: 9566919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
    Kralova J; Schatzle JD; Bargmann W; Bose HR
    J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
    Diehl JA; McKinsey TA; Hannink M
    Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1.
    Stewart MD; Choi Y; Johnson GA; Yu-Lee LY; Bazer FW; Spencer TE
    Biol Reprod; 2002 Feb; 66(2):393-400. PubMed ID: 11804954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppression of SH3BGRL is important for v-Rel-mediated transformation.
    Majid SM; Liss AS; You M; Bose HR
    Oncogene; 2006 Feb; 25(5):756-68. PubMed ID: 16186799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation.
    Tong S; Liss AS; You M; Bose HR
    Oncogene; 2007 Apr; 26(16):2318-29. PubMed ID: 17016434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.
    You M; Ku PT; Hrdlicková R; Bose HR
    Mol Cell Biol; 1997 Dec; 17(12):7328-41. PubMed ID: 9372964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
    Sato T; Selleri C; Young NS; Maciejewski JP
    Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.
    Sato M; Suemori H; Hata N; Asagiri M; Ogasawara K; Nakao K; Nakaya T; Katsuki M; Noguchi S; Tanaka N; Taniguchi T
    Immunity; 2000 Oct; 13(4):539-48. PubMed ID: 11070172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB.
    Grumont RJ; Gerondakis S
    J Exp Med; 2000 Apr; 191(8):1281-92. PubMed ID: 10770796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.
    Petrenko O; Ischenko I; Enrietto PJ
    Oncogene; 1997 Oct; 15(14):1671-80. PubMed ID: 9349500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of gene expression by nuclear and cytoplasmic rel proteins.
    Hannink M; Temin HM
    Mol Cell Biol; 1989 Oct; 9(10):4323-36. PubMed ID: 2555689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence comparison of avian interferon regulatory factors and identification of the avian CEC-32 cell as a quail cell line.
    Zöller B; Redman-Müller I; Nanda I; Guttenbach M; Dosch E; Schmid M; Zoorob R; Jungwirth C
    J Interferon Cytokine Res; 2000 Aug; 20(8):711-7. PubMed ID: 10954914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.